J Korean Med Sci.  2025 May;40(17):e150. 10.3346/jkms.2025.40.e150.

Use of Pulmonary Rehabilitation for Lung Cancer Patients in Korea: Analysis of the National Health Insurance Service Database

Affiliations
  • 1Department of Rehabilitation Medicine, Biomedical Research Institute, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea
  • 2Biomedical Research Institute, Pusan National University Hospital, Busan, Korea
  • 3Department of Physical Therapy, Rehabilitation of Medicine, Pusan National University Hospital, Busan, Korea
  • 4Department of Biostatistics, Clinical Trial Center, Biomedical Research Institute, Pusan National University Hospital, Busan, Korea
  • 5Department of Thoracic and Cardiovascular Surgery, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea
  • 6Department of Internal Medicine, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea

Abstract

This study aimed to assess the utilization trends of pulmonary rehabilitation (PR) among lung cancer patients in Korea using the National Health Insurance Service (NHIS) database (2017 to 2021). PR was introduced and covered under the NHIS in 2016, primarily for chronic obstructive pulmonary disease, but recent evidence suggests its benefits for lung cancer patients. Data extraction was based on Korea Informative Classification of Diseases 8th revision codes C33 and C34, with PR prescriptions identified by codes MM440 and MM290. Descriptive statistical analysis was performed, and propensity score matching was used for comparison between PR and non-PR groups. Results showed a significant increase in PR utilization, with the number of patients receiving PR (MM440) rising from 1,002 in 2017 to 3,723 in 2021, indicating a 3.7-fold increase. However, the proportion of patients receiving PR remained low at 2.9% in 2021. Enhanced access to PR services and improved evaluation strategies are essential for optimizing patient outcomes.

Keyword

Lung Neoplasm; Pulmonary Rehabilitation; Exercise Test; Health Insurance; Big Data

Figure

  • Fig. 1 Annual number of patients with lung cancer prescribed PR and average number of PR sessions per patient. (A) MM440, (B) MM290.PR = pulmonary rehabilitation.

  • Fig. 2 Annual trend of pulmonary rehabilitation implementation rate. (A) MM440, (B) MM290.

  • Fig. 3 Regional distribution of PR (MM440) implementation rates in 2017 and 2021. Maps of Korea show PR implementation rates per 100,000 population in each region in (A) 2017 and (B) 2021.PR = pulmonary rehabilitation.


Reference

1. Park EH, Jung KW, Park NJ, Kang MJ, Yun EH, Kim HJ, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2021. Cancer Res Treat. 2024; 56(2):357–371. PMID: 38487832.
2. Shin YB. Pulmonary rehabilitation for patients with COPD and asthma. Ann Cardiopulm Rehabil. 2021; 1(1):23–32.
3. Zhai R, Yu X, Shafer A, Wain JC, Christiani DC. The impact of coexisting COPD on survival of patients with early-stage non-small cell lung cancer undergoing surgical resection. Chest. 2014; 145(2):346–353. PMID: 24008835.
4. Gravier FE, Smondack P, Prieur G, Medrinal C, Combret Y, Muir JF, et al. Effects of exercise training in people with non-small cell lung cancer before lung resection: a systematic review and meta-analysis. Thorax. 2022; 77(5):486–496. PMID: 34429375.
5. Wei S, Chen F, Liu R, Fu D, Wang Y, Zhang B, et al. Outcomes of lobectomy on pulmonary function for early stage non-small cell lung cancer (NSCLC) patients with chronic obstructive pulmonary disease (COPD). Thorac Cancer. 2020; 11(7):1784–1789. PMID: 32374491.
6. Yoon JA, Hong BY. Cancer rehabilitation fact sheet in Korea. Ann Rehabil Med. 2022; 46(4):155–162. PMID: 36070997.
7. Catho H, Guigard S, Toffart AC, Frey G, Chollier T, Brichon PY, et al. What are the barriers to the completion of a home-based rehabilitation programme for patients awaiting surgery for lung cancer: a prospective observational study. BMJ Open. 2021; 11(2):e041907.
8. Mao X, Ni Y, Niu Y, Jiang L. The clinical value of pulmonary rehabilitation in reducing postoperative complications and mortality of lung cancer resection: a systematic review and meta-analysis. Front Surg. 2021; 8:685485. PMID: 34646857.
9. Divisi D, Di Francesco C, Di Leonardo G, Crisci R. Preoperative pulmonary rehabilitation in patients with lung cancer and chronic obstructive pulmonary disease. Eur J Cardiothorac Surg. 2013; 43(2):293–296. PMID: 22588033.
10. Zhou K, Su J, Lai Y, Li P, Li S, Che G. Short-term inpatient-based high-intensive pulmonary rehabilitation for lung cancer patients: is it feasible and effective? J Thorac Dis. 2017; 9(11):4486–4493. PMID: 29268518.
11. Sanches EE, Aupers E, Sakran N, Navalta J, Kostka T, Pouwels S. Barriers and facilitators in rehabilitation in chronic diseases and after surgery: Is it a matter of adherence? Cureus. 2021; 13(12):e20173. PMID: 35003999.
12. Goldsmith I, Chesterfield-Thomas G, Toghill H. Pre-treatment optimization with pulmonary rehabilitation in lung cancer: making the inoperable patients operable. EClinicalMedicine. 2020; 31:100663. PMID: 33554075.
13. Voorn MJJ, Bongers BC, van Kampen-van den Boogaart VEM, Driessen EJM, Janssen-Heijnen MLG. Feasibility of rehabilitation during chemoradiotherapy among patients with stage III non-small cell lung cancer: a proof-of-concept study. Cancers (Basel). 2022; 14(10):2387. PMID: 35625990.
14. Choi JY, Kim KU, Kim DK, Kim YI, Kim TH, Lee WY, et al. Pulmonary rehabilitation is associated with decreased exacerbation and mortality in patients with COPD: a nationwide Korean study. Chest. 2024; 165(2):313–322. PMID: 37806492.
15. Sclauser Pessoa IM, Franco Parreira V, Fregonezi GA, Sheel AW, Chung F, Reid WD. Reference values for maximal inspiratory pressure: a systematic review. Can Respir J. 2014; 21(1):43–50. PMID: 24137574.
16. Park TS, Tak YJ, Ra Y, Kim J, Han SH, Kim SH, et al. Reference respiratory muscle strength values and a prediction equation using physical functions for pulmonary rehabilitation in Korea. J Korean Med Sci. 2023; 38(40):e325. PMID: 37846788.
17. Beaumont M, Forget P, Couturaud F, Reychler G. Effects of inspiratory muscle training in COPD patients: a systematic review and meta-analysis. Clin Respir J. 2018; 12(7):2178–2188. PMID: 29665262.
18. Brocki BC, Andreasen JJ, Westerdahl E. Inspiratory muscle training in high-risk patients following lung resection may prevent a postoperative decline in physical activity level. Integr Cancer Ther. 2018; 17(4):1095–1102. PMID: 30136589.
19. Sato S, Miyazaki S, Tamaki A, Yoshimura Y, Arai H, Fujiwara D, et al. Respiratory sarcopenia: a position paper by four professional organizations. Geriatr Gerontol Int. 2023; 23(1):5–15. PMID: 36479799.
20. Stringer W, Marciniuk D. The role of cardiopulmonary exercise testing (CPET) in pulmonary rehabilitation (PR) of chronic obstructive pulmonary disease (COPD) patients. COPD. 2018; 15(6):621–631. PMID: 30595047.
21. Brunelli A, Kim AW, Berger KI, Addrizzo-Harris DJ. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013; 143(5):Suppl. e166S–e190S. PMID: 23649437.
Full Text Links
  • JKMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2025 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr